![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.indianpharmapost.com/news/astrazeneca-completes-acquisition-of-icosavax-15295
https://www.biospace.com/article/astrazeneca-buys-into-rsv-vaccine-market-with-potential-1-1b-icosavax-purchase/
https://investors.icosavax.com/news-releases/news-release-details/icosavax-announces-positive-topline-interim-phase-2-results
https://www.globenewswire.com//news-release/2023/11/14/2780510/0/en/Icosavax-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2023/11/08/2776171/0/en/Icosavax-to-Participate-in-the-Jefferies-London-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/10/31/2770090/0/en/Icosavax-to-Participate-in-the-Guggenheim-Healthcare-Talks-5th-Annual-Inflammation-Neurology-Immunology-INI-Conference.html
https://www.globenewswire.com//news-release/2023/09/19/2745511/0/en/Icosavax-to-Participate-in-the-Cantor-Fitzgerald-Global-Healthcare-Conference-2023.html
https://www.globenewswire.com/news-release/2023/08/14/2724973/0/en/Icosavax-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2023/08/08/2721149/0/en/Icosavax-Reports-Positive-12-Month-Durability-Data-for-VLP-Vaccine-Candidate-IVX-121-Against-RSV-and-Initial-Evidence-for-Revaccination-Potential.html
https://finance.yahoo.com/news/icosavax-inc-nasdaq-icvx-largely-130022174.html